KDM4A - Lysine Specific Demethylase 4A

KDM4A - Lysine Specific Demethylase 4A

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">KDM4A</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>KDM4A</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Lysine Specific Demethylase 4A</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>1p34.2</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>9682</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000133195</td>
</tr>
<tr>
<td class="label">OMIM ID</td>
<td>605095</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>O75173</td>
</tr>
<tr>
<td class="label">Protein Family</td>
<td>JMJD2 family (Jumonji C domain demethylase)</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td>Alzheimer's Disease, Parkinson's Disease, Cancer, Intellectual Disability</td>
</tr>
</table>

KDM4A (Lysine Specific Demethylase 4A)

Overview

KDM4A - Lysine Specific Demethylase 4A

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">KDM4A</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>KDM4A</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Lysine Specific Demethylase 4A</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>1p34.2</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>9682</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000133195</td>
</tr>
<tr>
<td class="label">OMIM ID</td>
<td>605095</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>O75173</td>
</tr>
<tr>
<td class="label">Protein Family</td>
<td>JMJD2 family (Jumonji C domain demethylase)</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td>Alzheimer's Disease, Parkinson's Disease, Cancer, Intellectual Disability</td>
</tr>
</table>

KDM4A (Lysine Specific Demethylase 4A)

Overview

KDM4A (also known as JMJD2A) encodes a lysine-specific histone demethylase that catalyzes the removal of methyl groups from histone lysine residues, primarily H3K9me3 and H3K36me3. This enzyme belongs to the JMJD2 family (Jumonji C domain demethylase) and functions as a critical epigenetic regulator of chromatin accessibility and gene expression["@kooistra2012"]. In the nervous system, KDM4A plays essential roles in neuronal development, synaptic plasticity, memory formation, and response to cellular stress["@huang2019"].

KDM4A has emerged as an important player in neurodegenerative diseases. Altered KDM4A expression and activity have been documented in Alzheimer's disease brain tissues, where it contributes to dysregulated chromatin states and impaired gene expression programs essential for neuronal survival["@cheng2019"]. The enzyme's ability to dynamically regulate histone methylation makes it a key component of epigenetic homeostasis in neurons.

Gene Structure and Organization

Genomic Context

The KDM4A gene is located on chromosome 1p34.2, spanning approximately 28 kilobases. The gene consists of 22 exons that generate multiple transcript variants through alternative splicing. The genomic region flanking KDM4A shows conservation across vertebrates, reflecting its essential cellular functions.

Alternative Transcripts

Multiple KDM4A transcript variants have been characterized:

• Full-length isoform: The canonical transcript encodes a 1054-amino-acid protein with the complete JmjN and JmjC domains.
• Shorter isoforms: Alternative splicing produces truncated variants lacking portions of the C-terminal regulatory domains.
• Brain-specific variants: Neuronal cells express specific isoforms with unique N-terminal sequences.

Protein Structure and Biochemistry

Catalytic Domains

KDM4A contains several structurally and functionally distinct domains[@klose2006]:

JmjN Domain: The N-terminal Jumonji N domain (approximately 100 residues) is unique to the JMJD2 family. This domain stabilizes the catalytic core and isRequired for demethylase activity. The JmjN domain forms a antiparallel beta-sheet that interfaces with the JmjC domain.

JmjC Domain: The catalytic Jumonji C domain (approximately 250 residues) contains the active site. This domain is a member of the 2-oxoglutarate-dependent dioxygenase superfamily. The active site contains residues that coordinate the essential iron cofactor (Fe²⁺) and binding sites for 2-oxoglutarate (alpha-ketoglutarate).

Plant Homeodomain (PHD) Finger: The C-terminal PHD finger functions as a reader domain that recognizes specific histone modifications. This domain binds to H3K4me3, facilitating targeting to active chromatin regions.

Tudor Domain: The tandem Tudor domain recognizes methylated lysine residues, particularly H3K4me3 and H3K9me3. This domain provides substrate specificity and contributes to chromatin targeting.

Catalytic Mechanism

KDM4A demethylates histone lysine residues through a Fe²⁺- and 2-oxoglutarate-dependent mechanism[@copeland2013]:

Normal Physiological Function

Epigenetic Regulation in Neurons

KDM4A modifies histone methylation states to regulate gene expression programs critical for neuronal function[@huang2019]:

H3K9me3 Demethylation: KDM4A removes the repressive H3K9me3 mark, enabling expression of genes involved in neuronal activation and plasticity. H3K9me3 is associated with constitutive heterochromatin, and its removal is required for transcriptional activation.

H3K36me3 Demethylation: KDM4A demethylates H3K36me3, a mark associated with active transcription. This activity balances the deposition of active marks during transcriptional cycling.

Cross-talk with Other Demethylases: KDM4A function is coordinated with other histone demethylases, including KDM4B, KDM4C, and KDM5 family members.

Roles in the Nervous System

KDM4A participates in multiple neuronal processes[@kohrs2016]:

Neuronal Development: During neurogenesis, KDM4A regulates genes controlling differentiation, migration, and maturation of neuronal precursors.

Synaptic Plasticity: At synapses, KDM4A modulates the epigenetic landscape to enable long-term changes in synaptic strength and dendritic remodeling.

Memory Formation: KDM4A activity is required for memory consolidation and the formation of long-term memories. KDM4A-regulated genes include immediate-early genes essential for synaptic remodeling[@pardo2017].

Response to Stress: Neurons upregulate KDM4A in response to oxidative stress, DNA damage, and other Cellular challenges.

Circadian Rhythm Regulation: KDM4A participates in cyclical gene regulation linked to circadian rhythms[@metivier2008].

Role in Neurodegenerative Diseases

Alzheimer's Disease

KDM4A dysregulation contributes to multiple aspects of AD pathogenesis[@cheng2019][@chen2018]:

Histone Methylation Imbalance: AD brain shows altered H3K9me3 and H3K36me3 patterns, reflecting KDM4A dysfunction. The balance between methyltransferases and demethylases is disrupted.

Transcriptional Dysregulation: KDM4A target genes involved in synaptic function, vesicle trafficking, and neuronal survival show altered expression in AD.

Tau Pathology: KDM4A interacts with tau pathology—neurons with high tau burden show reduced KDM4A nuclear localization.

Compensatory Upregulation: Early AD stages show compensatory KDM4A upregulation, but this response diminishes with disease progression.

Therapeutic Potential: KDM4A-modulating compounds are being explored to restore proper epigenetic states in AD.

Parkinson's Disease

In PD, KDM4A contributes to disease pathogenesis through:

Alpha-Synuclein Regulation: KDM4A regulates genes involved in alpha-synuclein expression and aggregation propensity.

Oxidative Stress Response: The oxidative stress response is dysregulated due to impaired KDM4A function.

Mitochondrial Function: Genes controlling mitochondrial dynamics are epigenetically dysregulated in PD.

Neuroinflammation: KDM4A in glial cells regulates inflammatory gene expression[@zhang2018].

Other Neurodegenerative Conditions

• Huntington's Disease: KDM4A regulates genes containing CAG repeat expansions.
• Amyotrophic Lateral Sclerosis: Epigenetic dysregulation involves KDM4Atarget genes.
• Frontotemporal Dementia: Altered H3K9me3 patterns reflect KDM4A dysfunction.

Therapeutic Targeting

Small Molecule Inhibitors

KDM4A is being targeted by small molecule inhibitors for various therapeutic applications[@bjorkman2012]:

JmjC Domain Inhibitors: Compounds that compete with 2-oxoglutarate binding inhibit demethylase activity.

Metal Chelators: 2-Oxoglutarate analogs that bind the iron cofactor.

Substrate Analogs: Peptide-based inhibitors mimicking methylated histone tails.

Challenges

Developing brain-penetrant KDM4A-targeted compounds remains challenging:

• Achieving sufficient blood-brain barrier penetration
• Selectivity over other JmjC domain demethylases
• Balancing demethylase inhibition with essential functions

Gene Regulation

Transcriptional Control

KDM4A expression is regulated at the transcriptional level:

• Sp1/Sp3: GC-rich promoter regulated by Sp1 and Sp3.
• p53: KDM4A is a p53 target gene induced in response to DNA damage.
• Myc: Myc transcription factors regulate KDM4A in proliferating cells.

Post-Translational Regulation

KDM4A activity is regulated by post-translational modifications:

• Phosphorylation: Kinases modify KDM4A to alter its activity and localization.
• Acetylation: Acetylation of lysine residues affects chromatin binding.
• Sumoylation: SUMO modification regulates nuclear localization.
• Ubiquitination: KDM4A undergoes ubiquitination and degradation.

Regulation by Metabolites

As a 2-oxoglutarate-dependent enzyme, KDM4A is sensitive to cellular metabolism:

• 2-Oxoglutarate: Substrate for the demethylation reaction.
• Succinate and Fumarate: Accumulation of these metabolites competes with 2-oxoglutarate.
• Ascorbate: Required as an essential cofactor for iron activity.

Expression Patterns

Brain Expression

KDM4A is expressed throughout the brain[@IWAMOTO2007]:

• Hippocampus: High expression in CA1-CA3 regions and dentate gyrus.
• Cerebral Cortex: Layer-specific expression in cortical neurons.
• Cerebellum: Moderate expression in Purkinje cells and granule cells.
• Substantia Nigra: Expression in dopaminergic neurons.

Cell-Type Specificity

• Neurons: High expression in excitatory and inhibitory neurons.
• Astrocytes: Lower expression than neurons.
• Microglia: Expression increases in activated states.

Interactions and Pathways

Protein Interactions

KDM4A interacts with multiple protein partners:

• HDAC1/2: Histone deacetylases coordinate to regulate chromatin states.
• REST: The neuronal repressor REST recruits KDM4A to target genes.
• POU2F2: Transcription factors that recruit KDM4A.
• L3MBTL1: Methyl-lysine binding protein.

Signaling Pathways

KDM4A participates in several signaling cascades:

• p53 Pathway: DNA damage induces KDM4A expression.
• MAPK/ERK: Growth factor signaling modulates KDM4A.
• Notch Pathway: Developmental notch signaling regulates KDM4A.

Research Models

Animal Models

• Knockout Mice: KDM4A knockout is embryonic lethal.
• Conditional Knockouts: Tissue-specific knockouts reveal essential functions.
• Transgenic Models: Overexpression models for gain-of-function studies.

Cell Models

• Primary Neurons: Rodent and human neurons for mechanistic studies.
• iPSC-Derived Neurons: Patient-derived neurons for disease modeling.
• Cell Lines: HEK293, SH-SY5Y, and other lines for biochemistry.

Summary

KDM4A encodes a critical histone demethylase that regulates chromatin states in neurons. Its role in modulating H3K9me3 and H3K36me3 makes it essential for proper gene expression programs controlling neuronal development, synaptic plasticity, and memory formation. Dysregulated KDM4A function contributes to Alzheimer's disease, Parkinson's disease, and other neurodegenerative conditions. Therapeutic targeting of KDM4A represents a promising approach for treating these diseases, though significant challenges remain in developing brain-penetrant selective compounds.

See Also

• [KDM4A Protein](/proteins/kdm4a-protein)
• [Histone Methylation](/entities/histone-methylation)
• [Epigenetics in Neurodegeneration](/mechanisms/epigenetic-regulation-neurodegeneration)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Chromatin Remodeling](/mechanisms/chromatin-remodeling)
• [JMJD2 Family](/proteins/jmjd2-protein)
• [Gene Expression Regulation](/mechanisms/gene-expression-regulation)

References